Research Papers:

Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network

Yuze Cao, Peng Wang, Shangwei Ning, Wenbiao Xiao, Bo Xiao and Xia Li _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:41737-41747. https://doi.org/10.18632/oncotarget.9569

Metrics: PDF 1524 views  |   HTML 2482 views  |   ?  


Yuze Cao1, Peng Wang2, Shangwei Ning2, Wenbiao Xiao1, Bo Xiao1, Xia Li2

1Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan Province, China

2College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang Province, China

Correspondence to:

Xia Li, email: lixia@hrbmu.edu.cn

Bo Xiao, email: xiaobo_xy@126.com

Keywords: lncRNA, ceRNA network, topology, prognostic biomarker, synergistic regulation

Received: March 18, 2016     Accepted: May 10, 2016     Published: May 24, 2016


Glioblastoma multiforme (GBM) is a highly malignant brain tumor associated with a poor prognosis. Cross-talk between competitive endogenous RNAs (ceRNAs) plays a critical role in tumor development and physiology. In this study, we present a multi-step computational approach to construct a functional GBM long non-coding RNA (lncRNA)-mediated ceRNA network (LMCN) by integrating genome-wide lncRNA and mRNA expression profiles, miRNA-target interactions, functional analyses, and clinical survival analyses. LncRNAs in the LMCN exhibited specific topological features consistent with a regulatory association with coding mRNAs across GBM pathology. We determined that the lncRNA MCM3AP-AS was involved in RNA processing and cell cycle-related functions, and was correlated with patient survival. MCM3AP-AS and MIR17HG acted synergistically to regulate mRNAs in a network module of the competitive LMCN. By integrating the expression profile of this module into a risk model, we stratified GBM patients in both the The Cancer Genome Atlas and an independent GBM dataset into distinct risk groups. Finally, survival analyses demonstrated that the lncRNAs and network module are potential prognostic biomarkers for GBM. Thus, ceRNAs could accelerate biomarker discovery and therapeutic development in GBM.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 9569